Literature DB >> 18090315

Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice.

Nobuhiko Taniuchi1, Tetsuhiro Niidome, Yasuaki Goto, Akinori Akaike, Takeshi Kihara, Hachiro Sugimoto.   

Abstract

A recent hypothesis suggests that there is impaired hippocampal neurogenesis in Alzheimer's disease. Here we examined the proliferation, the first stage in neurogenesis, of hippocampal progenitor cells in amyloid precursor protein with Swedish mutation and presenilin-1 with deletion of exon 9 (APPswe/PS1dE9) transgenic mice. Compared with age-matched wild-type mice, transgenic mice at 5 months of age with low amyloid beta-peptide (Abeta) levels and subtle Abeta deposits showed normal proliferation of hippocampal progenitor cells; however, transgenic mice at 9 months of age with high Abeta levels and numerous Abeta deposits showed decreased proliferation of these cells. The number of proliferating cells in male transgenic mice was indistinguishable from that in female transgenic mice. These results indicate that neurogenesis is decreased with degrees of Abeta pathology, and that there is no gender difference in their proliferation in APPswe/PS1dE9 transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090315     DOI: 10.1097/WNR.0b013e3282f1c9e9

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  34 in total

1.  Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.

Authors:  Michael Demars; Yuan-Shih Hu; Archana Gadadhar; Orly Lazarov
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

2.  Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.

Authors:  Chanpreet Singh; Lifei Liu; Jun Ming Wang; Ronald W Irwin; Jia Yao; Shuhua Chen; Sherry Henry; Richard F Thompson; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

3.  Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.

Authors:  Junling Yang; Jinghong Kou; Robert Lalonde; Ken-Ichiro Fukuchi
Journal:  Brain Behav Immun       Date:  2017-05-17       Impact factor: 7.217

4.  Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics.

Authors:  Shailaja Kishan Rao; Jordan M Ross; Fiona E Harrison; Alexandra Bernardo; Randall S Reiserer; Ronald S Reiserer; James A Mobley; Michael P McDonald
Journal:  Neurobiol Dis       Date:  2015-03-25       Impact factor: 5.996

Review 5.  Altered neurogenesis in mouse models of Alzheimer disease.

Authors:  Oliver Wirths
Journal:  Neurogenesis (Austin)       Date:  2017-05-09

Review 6.  The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

Authors:  Zhi-dong Zhou; Christine Hui-shan Chan; Quan-hong Ma; Xiao-hong Xu; Zhi-cheng Xiao; Eng-king Tan
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

7.  Early Seizure Activity Accelerates Depletion of Hippocampal Neural Stem Cells and Impairs Spatial Discrimination in an Alzheimer's Disease Model.

Authors:  Chia-Hsuan Fu; Daniel Maxim Iascone; Iraklis Petrof; Anupam Hazra; Xiaohong Zhang; Mark S Pyfer; Umberto Tosi; Brian F Corbett; Jingli Cai; Jason Lee; Jin Park; Lorraine Iacovitti; Helen E Scharfman; Grigori Enikolopov; Jeannie Chin
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

Review 8.  Neurogenesis and Alzheimer's disease: at the crossroads.

Authors:  Orly Lazarov; Robert A Marr
Journal:  Exp Neurol       Date:  2009-08-19       Impact factor: 5.330

9.  Harnessing neurogenesis in the adult brain-A role in type 2 diabetes mellitus and Alzheimer's disease.

Authors:  Orly Lazarov; Richard D Minshall; Marcelo G Bonini
Journal:  Int Rev Neurobiol       Date:  2020       Impact factor: 3.230

10.  A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.

Authors:  Brian Spencer; Inder Verma; Paula Desplats; Dinorah Morvinski; Ed Rockenstein; Anthony Adame; Eliezer Masliah
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.